These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31818523)

  • 1. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis.
    Huang D; Lei S; Wu Y; Weng M; Zhou Y; Xu J; Xia D; Xu E; Lai M; Zhang H
    Clin Nutr; 2020 Aug; 39(8):2525-2538. PubMed ID: 31784301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.
    Ala M
    Curr Diabetes Rev; 2022; 18(8):e051121197762. PubMed ID: 34749618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
    Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes.
    Demb J; Yaseyyedi A; Liu L; Bustamante R; Earles A; Ghosh P; Gutkind JS; Gawron AJ; Kaltenbach TR; Martinez ME; Gupta S
    Clin Transl Gastroenterol; 2019 Nov; 10(11):e00092. PubMed ID: 31770138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
    Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
    J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
    Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
    Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
    BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.
    Jung YS; Park CH; Eun CS; Park DI; Han DS
    J Gastroenterol Hepatol; 2017 May; 32(5):957-965. PubMed ID: 28449338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
    Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.